BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37184688)

  • 21. Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experience.
    Ju MR; Yopp AC
    Ann Gastroenterol Surg; 2020 May; 4(3):208-215. PubMed ID: 32490334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
    Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
    Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in patients with recurrent hepatocellular carcinoma treated with salvage liver transplantation: a single-center study.
    Wang P; Li H; Shi B; Que W; Wang C; Fan J; Peng Z; Zhong L
    Oncotarget; 2016 Jun; 7(23):35071-83. PubMed ID: 27145461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of liver transplantation for hepatocellular carcinoma -- a single center experience.
    Iacob R; Iacob S; Gheorghe L; Gheorghe C; Hrehoreţ D; Brașoveanu V; Croitoru A; Herlea V; Popescu I
    Chirurgia (Bucur); 2013; 108(4):446-50. PubMed ID: 23958083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidental hepatocellular carcinoma after liver transplantation: Prevalence, histopathological features and prognostic impact.
    Pérez P; Rodríguez-Perálvarez M; Guerrero L; González V; Sánchez R; Centeno M; Poyato A; Briceño J; Sánchez-Frías M; Montero JL; De la Mata M
    PLoS One; 2017; 12(4):e0175010. PubMed ID: 28403219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AFP score and metroticket 2.0 perform similarly and could be used in a "within-ALL" clinical decision tool.
    Piñero F; Costentin C; Degroote H; Notarpaolo A; Boin IF; Boudjema K; Baccaro C; Chagas A; Bachellier P; Ettorre GM; Poniachik J; Muscari F; Dibenedetto F; Duque SH; Salame E; Cillo U; Marciano S; Vanlemmens C; Fagiuoli S; Carrilho F; Cherqui D; Burra P; Van Vlierberghe H; Lai Q; Silva M; Rubinstein F; Duvoux C; ; ; ; ;
    JHEP Rep; 2023 Feb; 5(2):100644. PubMed ID: 36691474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recipient liver function before liver transplantation influences post-transplantation survival in patients with HCC.
    Foerster F; Mittler J; Darstein F; Heise M; Marquardt JU; Wörns MA; Weinmann A; Sälter L; Hoppe-Lotichius M; Heinrich S; Kloeckner R; Pitton MB; Schattenberg JM; Sprinzl MF; Düber C; Otto G; Lang H; Galle PR; Zimmermann T
    Eur J Intern Med; 2018 Sep; 55():57-65. PubMed ID: 29859798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advantage of early liver transplantation whenever indicated for hepatocellular carcinoma recurrence after primary liver resection.
    Chan KM; Wu TH; Cheng CH; Lee CF; Wu TJ; Chou HS; Lee WC
    Biomed J; 2019 Oct; 42(5):335-342. PubMed ID: 31783994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-fetoprotein-adjusted-to-HCC-size criteria are associated with favourable survival after liver transplantation for hepatocellular carcinoma.
    Meischl T; Rasoul-Rockenschaub S; Győri G; Scheiner B; Trauner M; Soliman T; Berlakovich G; Pinter M
    United European Gastroenterol J; 2021 Mar; 9(2):209-219. PubMed ID: 32741316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver transplantation for hepatocellular carcinoma within the Milan criteria versus the University of California San Francisco criteria: a comparative study.
    Abdelfattah MR; Elsiesy H; Al-Manea H; Broering DC
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):398-403. PubMed ID: 29280920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria.
    Herrero JI; Sangro B; Pardo F; Quiroga J; Iñarrairaegui M; Rotellar F; Montiel C; Alegre F; Prieto J
    Liver Transpl; 2008 Mar; 14(3):272-8. PubMed ID: 18306328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors, Presentation, and Treatment Outcomes of Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Large Single Center Experience.
    Ekpanyapong S; Philips N; Loza BL; Abt P; Furth EE; Tondon R; Khungar V; Olthoff K; Shaked A; Hoteit MA; Reddy KR
    J Clin Exp Hepatol; 2020; 10(4):304-315. PubMed ID: 32655233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
    Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
    Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients with non-[18 F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation.
    Kornberg A; Küpper B; Tannapfel A; Büchler P; Krause B; Witt U; Gottschild D; Friess H
    Liver Transpl; 2012 Jan; 18(1):53-61. PubMed ID: 21850692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
    Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
    Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant.
    Cucchetti A; Serenari M; Sposito C; Di Sandro S; Mosconi C; Vicentin I; Garanzini E; Mazzaferro V; De Carlis L; Golfieri R; Spreafico C; Vanzulli A; Buscemi V; Ravaioli M; Ercolani G; Pinna AD; Cescon M
    J Hepatol; 2020 Aug; 73(2):342-348. PubMed ID: 32201284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor Polymorphisms of Toll-like Receptor 4 rs1927914 Associated with the Risk of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.
    Shi G; Wang C; Zhang P; Ji L; Xu S; Tan X; Li H
    Arch Med Res; 2017 Aug; 48(6):553-560. PubMed ID: 29221801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West.
    Lai Q; Avolio AW; Lerut J; Singh G; Chan SC; Berloco PB; Tisone G; Agnes S; Chok KS; Sharr W; Rossi M; Manzia TM; Lo CM
    J Hepatol; 2012 Nov; 57(5):974-9. PubMed ID: 22771712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver transplantation for hepatocellular carcinoma: current topics in France.
    Scatton O; Liddo G; Belghiti J
    J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):567-73. PubMed ID: 19760361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.